PharVision Advisers’s Rivian RIVN Stock Holding History

PharVision Advisers’s Portfolio RIVN Stock Details RIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,162	Closed	-$164K	–	402
2025 Q1	$164K	Buy	+13,162	New	+$166K	0.23%	221

Other funds holding RIVN

ACI

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PharVision Advisers's RIVN Position: Q2 2025 in Review

PharVision Advisers sold out of Rivian (RIVN) in Q2 2025, closing a stake of 13,162 shares — an estimated $164K sold.

PharVision Advisers first reported a position in RIVN in Q1 2025 and held it in 1 quarter. The position peaked at $164K in Q1 2025. 755 funds tracked by Wall St. Rank hold RIVN as of Q2 2025.

PharVision Advisers reported no remaining Rivian position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 13,162 Rivian shares in Q2 2025, an estimated $164K.
PharVision Advisers first reported a position in Rivian in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Rivian position peaked at $164K in Q1 2025.
755 funds tracked by Wall St. Rank held Rivian as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.